277 related articles for article (PubMed ID: 22380911)
21. [Significance of hepatitis B core antibody as the only marker of hepatitis B infection].
Colomina-Rodríguez J; González-García D; Burgos-Teruel A; Fernández-Lorenz N; Guerrero-Espejo A
Enferm Infecc Microbiol Clin; 2005 Feb; 23(2):80-5. PubMed ID: 15743579
[TBL] [Abstract][Full Text] [Related]
22. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
[TBL] [Abstract][Full Text] [Related]
23. Broad Range of Hepatitis B Virus (HBV) Patterns, Dual Circulation of Quasi-Subgenotype A3 and HBV/E and Heterogeneous HBV Mutations in HIV-Positive Patients in Gabon.
Bivigou-Mboumba B; François-Souquière S; Deleplancque L; Sica J; Mouinga-Ondémé A; Amougou-Atsama M; Chaix ML; Njouom R; Rouet F
PLoS One; 2016; 11(1):e0143869. PubMed ID: 26764909
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of hepatitis B virus (HBV) co-infection in HBV serologically-negative South African HIV patients and retrospective evaluation of the clinical course of mono- and co-infection.
Firnhaber C; Chen CY; Evans D; Maskew M; Schulz D; Reyneke A; Kramvis A
Int J Infect Dis; 2012 Apr; 16(4):e268-72. PubMed ID: 22305987
[TBL] [Abstract][Full Text] [Related]
25. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
Nebbia G; Garcia-Diaz A; Ayliffe U; Smith C; Dervisevic S; Johnson M; Gilson R; Tedder R; Geretti AM
J Med Virol; 2007 Oct; 79(10):1464-71. PubMed ID: 17705185
[TBL] [Abstract][Full Text] [Related]
26. Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients.
Lo Re V; Frank I; Gross R; Dockter J; Linnen JM; Giachetti C; Tebas P; Stern J; Synnestvedt M; Localio AR; Kostman JR; Strom BL
J Acquir Immune Defic Syndr; 2007 Mar; 44(3):315-20. PubMed ID: 17159655
[TBL] [Abstract][Full Text] [Related]
27. Risk factors of isolated antibody against core antigen of hepatitis B virus: association with HIV infection and age but not hepatitis C virus infection.
Liang SH; Chen TJ; Lee SS; Tseng FC; Huang CK; Lai CH; Chiou CP; Wang JL; Chung HC; Lin JN; Kuo YC; Lin HH
J Acquir Immune Defic Syndr; 2010 Jun; 54(2):122-8. PubMed ID: 20386111
[TBL] [Abstract][Full Text] [Related]
28. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study.
Alizadeh Z; Milani S; Sharifi Z
Arch Iran Med; 2014 Feb; 17(2):106-7. PubMed ID: 24527970
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of hepatitis B virus infection among tuberculosis patients with or without HIV in Goiânia City, Brazil.
Aires RS; Matos MA; Lopes CL; Teles SA; Kozlowski AG; Silva AM; Filho JA; Lago BV; Mello FC; Martins RM
J Clin Virol; 2012 Aug; 54(4):327-31. PubMed ID: 22608842
[TBL] [Abstract][Full Text] [Related]
30. Occult hepatitis B virus infection in immunocompromised patients.
Jardim RN; Gonçales NS; Pereira JS; Fais VC; Gonçales Junior FL
Braz J Infect Dis; 2008 Aug; 12(4):300-5. PubMed ID: 19030729
[TBL] [Abstract][Full Text] [Related]
31. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
Rodríguez-Torres M; Gonzalez-Garcia J; Bräu N; Solá R; Moreno S; Rockstroh J; Smaill F; Mendes-Correa MC; DePamphilis J; Torriani FJ;
J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
[TBL] [Abstract][Full Text] [Related]
33. The significance of 'anti-HBc only' in the clinical virology laboratory.
Alhababi F; Sallam TA; Tong CY
J Clin Virol; 2003 Jul; 27(2):162-9. PubMed ID: 12829038
[TBL] [Abstract][Full Text] [Related]
34. Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks.
Oluyinka OO; Tong HV; Bui Tien S; Fagbami AH; Adekanle O; Ojurongbe O; Bock CT; Kremsner PG; Velavan TP
PLoS One; 2015; 10(7):e0131912. PubMed ID: 26148052
[TBL] [Abstract][Full Text] [Related]
35. Isolated anti-HBc among HIV-infected patients in Istanbul, Turkey.
Karaosmanoglu HK; Aydin OA; Nazlican O
HIV Clin Trials; 2013; 14(1):17-20. PubMed ID: 23372111
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of hepatitis B and delta according to HIV-type: a multi-country cross-sectional survey in West Africa.
Coffie PA; Tchounga BK; Bado G; Kabran M; Minta DK; Wandeler G; Gottlieb GS; Dabis F; Eholie SP; Ekouevi DK
BMC Infect Dis; 2017 Jul; 17(1):466. PubMed ID: 28676076
[TBL] [Abstract][Full Text] [Related]
37. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
[TBL] [Abstract][Full Text] [Related]
38. Occult hepatitis B virus infection in Korean patients with isolated anti-HBc.
Kang SY; Kim MH; Lee WI
Arch Virol; 2014 Feb; 159(2):227-33. PubMed ID: 23933720
[TBL] [Abstract][Full Text] [Related]
39. Sero-prevalence of Hepatitis B and C viral co-infections among HIV-1 infected ART-naïve individuals in Kumasi, Ghana.
Boateng R; Mutocheluh M; Dompreh A; Obiri-Yeboah D; Odame Anto E; Owusu M; Narkwa PW
PLoS One; 2019; 14(4):e0215377. PubMed ID: 31002687
[TBL] [Abstract][Full Text] [Related]
40. Toxoplasma gondii, HBV, and HCV co-infection and their correlation with CD4 cells among Iranian HIV-positive patients.
Bazmjoo A; Bagherzadeh MA; Raoofi R; Taghipour A; Mazaherifar S; Sotoodeh H; Ostadi Z; Shadmand E; Jahromi MAM; Abdoli A
Immun Inflamm Dis; 2023 Feb; 11(2):e794. PubMed ID: 36840494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
